SARS-CoV-2: A synergy to the Alzheimer’s disease

1Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Abstract

COVID-19 was a nightmare in humankind’s history that challenged our advanced medical technology. All credit goes to the researchers who played a crucial role in curbing COVID-19 and proved our medical technology supremacy. However, COVID-19 has left some mysterious scars on human well-being. It is believed that COVID-19 has a significant negative impact on various cardiovascular (CVS) and central nervous system (CNS) diseases, especially in the case of CNS diseases like Alzheimer's. Surprisingly, COVID-19 affects the respiratory system, whereas Alzheimer's disease (AD) alters brain function. To explain this phenomenon, several hypotheses were proposed, but the mechanism needs to be clearly understood. Another critical thing to be concerned about is that COVID-19 will worsen pre-existing conditions and lead to the onset of AD. In the race to curb COVID-19, the invention of vaccines was speeded up, and it is necessary to fight against COVID-19. However, postvaccination follow-up is mandatory when an individual is a victim of AD. In this review article, we compiled the various dreadful effects of the COVID-19 virus on AD, the Post effects of the virus on AD, and the effect of the COVID-19 vaccination on AD. This article provides a new direction for research concerning COVID-19 and AD.

Cite

CITATION STYLE

APA

Shaik, K. M., Kumar, D., Srikanth, P., & Nandi, S. (2025, February 1). SARS-CoV-2: A synergy to the Alzheimer’s disease. Journal of NeuroVirology. Springer Science and Business Media Deutschland GmbH. https://doi.org/10.1007/s13365-025-01247-w

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free